Enjoy complimentary customisation on priority with our Enterprise License!
The global RNAi technology market size has the potential to grow by USD 1.96 billion during 2020-2024. The market’s growth momentum will accelerate throughout the forecast period.
This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW) and application (cancer, infectious diseases, ophthalmic diseases, genetic diseases, and other diseases). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Alnylam Pharmaceuticals Inc., Arbutus Biopharma Corp., Arrowhead Pharmaceuticals Inc., Bio-Rad Laboratories Inc., Dicerna Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd., Horizon Discovery Group Plc, Merck KGaA, QIAGEN NV, and Thermo Fisher Scientific Inc.
Browse TOC and LoE with selected illustrations and example pages of RNAi technology market
Request a FREE sample now!
The RNAi technology market is currently fragmented. The degree of fragmentation will remain the same over the forecast period. The rising commercial approvals of RNAi therapy and increasing R&D in RNAi therapeutics are providing market vendors with significant growth opportunities. Horizon Discovery Group Plc, Merck KGaA, QIAGEN NV, and Thermo Fisher Scientific Inc. are a few of the substantial market participants.
Although the accelerating market growth momentum will offer immense business opportunities to vendors, a long approval process and stringent regulations will challenge the growth of many. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market positions, this RNAi technology market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of the companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. This RNAi technology market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of their future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading RNAi technology companies, including:
For more insights on the RNAi technology market share of various regions Request for a FREE sample now!
North America accounted for the largest market share in 2019. The growth in drug development and research and approval of RNAi therapeutics by regulatory authorities such as the US FDA are fueling the RNAi technology market growth in North America.
Almost 59% of the overall market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for RNAi technology in the region. The market growth rate in this region will be slower than that of Asia and ROW over the forecast period.
Request for a FREE sample and Get more information on the market contribution from various diagnostic methods segments
RNAi is finding considerable adoption in cancer treatments owing to its targeted treatment ability. RNAi technology can identify and target undruggable carcinogenic molecules. As a result, the use of technology is increasing in treating cancer. Furthermore, vendors are focusing on developing RNAi-based targeted cancer therapies using advanced lipid and polymer-based nanocarriers as a delivery platform. The rising prevalence of cancer is increasing the demand for RNAi technology. As a result, the RNAi technology market growth by the cancer segment will be significant over the forecast period.
The growth rate of the cancer segment is expected to be faster compared with the infectious diseases and ophthalmic diseases segment over the forecast period. This report provides an accurate prediction of the contribution of all the segments to the growth of the RNAi technology market size.
RNAi therapeutics deals with the use of the natural RNAi pathway to silence the disease-causing genes and knock down the production of the protein that expresses the condition. The technology is primarily used in the field of oncology. Many vital targets in cancer treatments have been proven undruggable. Therefore, siRNA is used to target the mRNA and not oncogene protein in cancer treatments, making the undruggable target accessible for small siRNA during cancer treatments. Leveraging the significant application of RNAi technology, therapeutic manufacturers are significantly focusing on the development of RNAi-based targeted cancer therapies, which are primarily advanced lipid and polymer-based nanocarriers. As the RNAi technology has made every gene in the human genome a druggable target, the demand for the technology as therapeutics is rising. As a result, the RNAi technology market growth over the forecast period is expected to be substantial over the forecast period.
Request for a FREE sample now!
We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY APPLICATION
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.